# L-MIND (NCT02399085)

> Open Label Study to Evaluate the Safety and Efficacy of Lenalidomide With MOR00208 in Patients With R-R DLBCL

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02399085
- Phase: PHASE2
- Status: COMPLETED
- Sponsor: MorphoSys AG
- Conditions: Diffuse Large B-cell Lymphoma
- Interventions: Tafasitamab; Lenalidomide
- Enrollment: 81
- Primary outcome: Number of Participants With Best Objective Response Rate (ORR)

## Commentary we found

- Podcasts: 27
- YouTube: 19
- X threads: 7

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=l-mind-nct02399085

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT02399085", "email": "<work email>"}; the inbox owner confirms by the emailed link.